The Second paediatric strategy forum, Medicinal Product Development for Mature B cell Malignancies in Children, jointly organised by ACCELERATE and the European Medicines Agency (EMA), will be held in London at the EMA premises on 13 and 14 November, 2017.
The event will focus on mature B cell malignancies (lymphoma and leukaemia) in children and is aimed to share information, in a pre-competitive setting, which will inform a paediatric drug development strategy and subsequent decisions and facilitate the developments of innovative medicines for the treatment of children with B cell malignancies.
More information on the objectives of this forum and link to the expressions of interest forms can be found on the EMA website: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2017/06/event_detail_001453.jsp&mid=WC0b01ac058004d5c3
And in the ACCELERATE website: http://www.accelerate-platform.eu/annual-conferences-2/upcoming-events/paediatric_strategy_forum/
Deadline to submit expressions of interest is 30 June, 2017.